top of page

19th IDS Congress
Paris 2023

23-27 May. 2023

The Immunology of Diabetes Society (IDS) is a scientific society dedicated to improving understanding and treatment of type 1 diabetes. IDS organizes a Congress every 18 months in major centres in Europe, North America and Asia/Oceania at which there are scientific presentations to further this goal.

Centre international de Conférences Sorbonne Université

4 place Jussieu - 44-55

75005 - Paris, France

logo ids_edited.jpg
*To submit before 15th February 2023

Confirmed Speakers

(by alphabetical order)

Peter Achenbach, Coralie Alabert, Mark Atkinson, Jean-François Bach, Burkhard Becher, Polly Bingley, Ezio Bonifacio, Marcela Brissova, Todd Brusko, Yi-Chun Chen, Jenny Couper, Mark M. Davis, Colin Dayan, Gerard Eberl, Decio L. Eizirik, Donna Farber, Carla Greenbaum, John Harris, Len Harrison, Matthias Hebrok, Kevan Herold, Heikki Hyoty, Eddie James, Matthew Johnson, Sally Kent, David Klatzmann, Jeffrey Krischer, Vito Lampasona, Peter E. Lipsky, Chantal Mathieu, Eoin McKinney, Cristina Nostro, Timo Otonkoski, Alberto Pugliese, Frédéric Rieux-Laucat, Bart Roep, Miguel Sanjuan, Pere Santamaria, Andrea Schietinger, Anath Shalev, Jeannette Soderberg, Tommi Suvitaival, Qizhi Tang, Timothy Tree, Taylor Triolo, Tommi Vatanen, Joseph Vieth, Carola Vinuesa, John Wentworth, Benjamin Youngblood, Tong Yue, Anette Ziegler

Schedule Fri 26th

 Friday 26th

8.20 am

Plenary 4

Circulating vs tissue immune cells: Donna Farber (Columbia University, New York)

9.00 am

11.00 am

Short Symposium 6: Theme to be defined

Talk 23 

Talk 24

Oral Abstract 20

Oral Abstract 21

Oral Abstract 22

Short Symposium 5: Blood omics

Talk 21: Sense and non-sense of multi-omics screening strategies in T1D: Tim Tree (King’s College, London)

Talk 22: CyTOF/RNAseq biomarkers in TrialNet/TEDDY at-risk subjects: Eoin McKinney (University of Cambridge)

Oral Abstract 17

Oral Abstract 18

Oral Abstract 19

12.30 am

Antibody Workshop session – Chairs: Peter Achenbach, Vito Lampasona

1.30 - 2.30 pm

10.30 - 11 am

2.30 pm

5.00 pm 

Long Symposium 5: Trials with new results

Talk 25: Coxsackievirus vaccination trial: Miguel Sanjuan (Provention)

Talk 26: Baricitinib in new-onset T1D: John Wentworth (University of Melbourne)

Talk 27: ActoBio Lactococcus lactis / Teplizumab: Chantal Mathieu (UZ Leuven)

Talk 28: Teplizumab update & biomarkers in TN10 prevention trial: Kevan Herold (Yale University, New Haven)

Talk 29: Low-dose IL-2, DIAB-IL2 trial: David Klatzmann (Sorbonne University, Paris)

Talk 30: Wrap-up: how good is good enough? Challenges and realities of T1D prevention/intervention: Anette Ziegler (Helmholtz, Munich)

Debate 2: type 1 diabetes endotypes: age and beyond

It all comes to age: Ezio Bonifacio (TUD, Dresden)

It is much more than age: Carla Greenbaum (Benaroya Research Institute, Seattle)

6.00 pm 

6.30 pm

Poster Blast 3 (31 to 45)


90” and 1 plain slide/each

Poster Session 3 (31 to 45)


90” and 1 plain slide/each

4.30 - 5.00 pm

7.45 pm

Dinner on your own

bottom of page